Financials and Filings

MGEN $2.73 $ - 0.10 (3.53%)

SEC Filings

Other Filings
Filing Description Filing Type Filing Date Event Date  
10-K 10-K 3/14/2019 12/31/2018
Registration Statement S-8 3/14/2019
8-K 8-K 3/13/2019 3/13/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K 8-K 2/8/2019 2/8/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
8-K 8-K 1/24/2019 1/24/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Entry into a Material Definitive Agreement.
8-K 8-K 1/10/2019 1/10/2019
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
13-D SC 13G 1/3/2019
8-K 8-K 12/20/2018 12/20/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
8-K 8-K 12/6/2018 12/4/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Other Events; and Financial Statements and Exhibits.
8-K 8-K 12/3/2018 12/2/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
13-D SC 13G/A 11/13/2018
8-K 8-K 11/7/2018 11/7/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
10-Q 10-Q 11/7/2018 9/30/2018
8-K 8-K 10/1/2018 10/1/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Regulation FD Disclosure and Financial Statements and Exhibits.
10-Q 10-Q 8/8/2018 6/30/2018
8-K 8-K 8/7/2018 8/7/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Results of Operations and Financial Condition and Financial Statements and Exhibits.
8-K 8-K 8/6/2018 8/6/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; and Financial Statements and Exhibits.
Registration Statement D 8/6/2018
8-K 8-K 7/10/2018 7/10/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Other Events and Financial Statements and Exhibits.
8-K 8-K 6/28/2018 6/27/2018
Abstract: 8-K filed by Miragen Therapeutics (MGEN) covering Submission of Matters to a Vote of Security Holder.

Displaying 1 to 20 (of 194 filings)